Community Webinar: FDA Approved Agamree and Catalyst Pathways

When:

April 25, 2024 1:00PM

Join Jett Foundation’s Community Webinar Series on April 25 at 1pm ET to hear an overview from the team at Catalyst Pharmaceuticals on their FDA approved Agamree & Catalyst Pathways. Registration is free and we hope you will tune in.

Catalyst Pharmaceuticals: FDA Approved Agamree & Catalyst Pathways
Thursday, April 25, 2024
1pm ET | 12pm CT | 11am MT | 10am PT

Carrie Ostrea, Sr. Manager of Patient Advocacy

Alison Anderson, MS, CGC, Medical Affairs Director, Neuromuscular

Maria Pandolfo, Sr. Vice President, Patient Services & Market Access

Our Community Webinar Series is focused on ensuring that our Duchenne community is better prepared for those unexpected moments, challenging medical decisions, and difficult stages when on a Duchenne journey.

No one ever expects Duchenne and there is no correct way to tackle a diagnosis, but we can always better prepare. This webinar series is an opportunity to equip yourself with more knowledge, resources, and tools for those real-life, often unanticipated, scenarios.